Clinical Trials Sponsored by Sanifit Therapeutics S. A.
Total 38 results
-
Sanifit Therapeutics S. A.CompletedCalciphylaxis | Calcific Uremic ArteriolopathyUnited States, Belgium, United Kingdom, Spain, Germany, Poland
-
Sanifit Therapeutics S. A.CompletedPeripheral Artery Disease | End Stage Renal Disease on DialysisUnited States
-
Sanifit Therapeutics S. A.CompletedCalciphylaxis | Calcific Uremic ArteriolopathyUnited States, United Kingdom
-
Sanifit Therapeutics S. A.Clinipace WorldwideCompletedCardiovascular Diseases | Cardiovascular Abnormalities | ESRD | Coronary Artery Calcification | Endstage Renal Disease | Calcifications, VascularSpain, United States, United Kingdom
-
Biosplice Therapeutics, Inc.NBCD A/SCompleted
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruitingSickle Cell DiseaseLebanon, Canada, Kenya, United Kingdom
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruiting
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Forma Therapeutics, Inc.RecruitingSickle Cell Disease | ThalassemiaUnited States, Lebanon, Canada
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruitingSickle Cell DiseaseUnited States, Italy, Spain, United Kingdom, France, Lebanon, Germany, Oman, Canada, Greece
-
Forma Therapeutics, Inc.CompletedCohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditionsUnited States, Korea, Republic of, Australia, United Kingdom, Spain, France
-
Novo Nordisk A/SSponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/SCompletedInflammation | Chronic Kidney Disease | Cardiovascular RiskJapan
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Bone Therapeutics S.ANordic Bioscience A/SCompletedSymptomatic Osteoarthritis of the KneeDenmark, Belgium, United Kingdom, Czechia, Hong Kong, Moldova, Republic of, Poland
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular DystrophyUnited States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedDuchenne Muscular Dystrophy | Becker Muscular DystrophyUnited States, Belgium, Australia, Canada, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedHemophilia A | Hemophilia BUnited States, Canada, France, Italy
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedAmino Acid Metabolism, Inborn ErrorsFrance, United Kingdom, Italy, Belgium, Germany, Switzerland
-
Forma Therapeutics, Inc.Emory UniversityNot yet recruitingSickle Cell DiseaseUnited States
-
Forma Therapeutics, Inc.Medpace, Inc.CompletedHealthy Volunteers | Sickle Cell DiseaseUnited States
-
Milton S. Hershey Medical CenterGenzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
Vivoryon Therapeutics N.V.Amsterdam UMC, location VUmc; Nordic Bioscience A/SCompletedEarly Alzheimers Disease | Mild Cognitive Impairment Due to ADNetherlands, Spain, Denmark, Germany, Poland
-
Allarity TherapeuticsMedical Prognosis Institute A/S; Smerud Medical Research International ASTerminatedRelapsed/Refractory Multiple MyelomaDenmark
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedRelapsed Acute Myelogenous LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Leukemia Lymphoblastic, Acute | Neoplasm RecurrentUnited States
-
Insight Therapeutics, LLCBrown University; Sanofi Pasteur, a Sanofi Company; Case Western Reserve UniversityActive, not recruitingInfluenza | Influenza, Human | Influenza -Like IllnessUnited States
-
Emory UniversityEli Lilly and Company; Novo Nordisk A/S; Sanofi; TakedaSuspended
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland
-
Universitaire Ziekenhuizen KU LeuvenNovo Nordisk A/S; Sanofi; Merck Sharp & Dohme LLC; Novartis; AstraZeneca; The National... and other collaboratorsCompletedDiabetes | Gestational DiabetesBelgium
-
Xuanwu Hospital, BeijingH. Lundbeck A/S; Hoffmann-La Roche; Genentech, Inc.; Life Molecular Imaging SA; APRINOIA... and other collaboratorsRecruitingAlzheimer DiseaseChina
-
Franciscus GasthuisNovo Nordisk A/S; Sanofi; Boehringer Ingelheim; Erasmus Medical Center; Biotronik... and other collaboratorsRecruitingHeart Failure | ObesityNetherlands
-
ERP Biomarker Qualification ConsortiumMerck Sharp & Dohme LLC; Novartis; Takeda; H. Lundbeck A/S; Astellas Pharma Inc; Alkermes... and other collaboratorsCompleted
-
ERP Biomarker Qualification ConsortiumMerck Sharp & Dohme LLC; Novartis; Takeda; H. Lundbeck A/S; Columbia University; Astellas... and other collaboratorsCompletedSchizophreniaUnited States
-
GRADE Study GroupBristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompletedType 2 Diabetes | Comparative Effectiveness of Glycemia-lowering MedicationsUnited States
-
Fondation Francophone pour la Recherche sur le...Eli Lilly and Company; Novo Nordisk A/S; Sanofi; Institut National de la Santé... and other collaboratorsRecruitingCardiovascular Diseases | Hypoglycemia | Diabetes Mellitus, Type 1 | Patient ParticipationFrance